{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T08:58:38Z","timestamp":1726045118668},"publisher-location":"Cham","reference-count":50,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030316341"},{"type":"electronic","value":"9783030316358"}],"license":[{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-31635-8_157","type":"book-chapter","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T17:05:22Z","timestamp":1569344722000},"page":"1283-1290","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of Different Radiotherapy Techniques for Locally Advanced Pancreatic Tumors"],"prefix":"10.1007","author":[{"given":"Adriana","family":"Gomes","sequence":"first","affiliation":[]},{"given":"Darlene","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Brigida","family":"C. Ferreira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,9,25]]},"reference":[{"issue":"2","key":"157_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12094-017-1679-1","volume":"20","author":"M Salgado","year":"2017","unstructured":"Salgado, M., Ar\u00e9valo, S., Hernando, O., et al.: Management of unresectable, locally advanced pancreatic adenocarcinoma. Clin. Transl. Oncol. 20(2), 113\u2013118 (2017)","journal-title":"Clin. Transl. Oncol."},{"issue":"22","key":"157_CR2","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/JCO.2016.67.5561","volume":"34","author":"E Balaban","year":"2016","unstructured":"Balaban, E., Mangu, P., Khorana, A., et al.: Locally advanced, unresectable pancreatic cancer: American society of clinical oncology clinical practice guideline. J. Clin. Oncol. 34(22), 2654\u20132657 (2016). Asco Special Article","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"157_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.semradonc.2013.11.003","volume":"24","author":"A Reese","year":"2014","unstructured":"Reese, A., Lu, W., William, R.: Utilization of intensity-modulated radiation therapy and image-guided radiation therapy in pancreatic cancer: is it beneficial? Semin. Radiat. Oncol. 24(2), 132\u2013139 (2014)","journal-title":"Semin. Radiat. Oncol."},{"issue":"3","key":"157_CR4","first-page":"157","volume":"2","author":"F Wang","year":"2011","unstructured":"Wang, F., Kumar, P.: The role of radiotherapy in management of pancreatic cancer. J. Gastrointestial Oncol. 2(3), 157\u2013162 (2011)","journal-title":"J. Gastrointestial Oncol."},{"issue":"5","key":"157_CR5","first-page":"466","volume":"17","author":"M Nandi","year":"2016","unstructured":"Nandi, M., Biswal, S., Bhattacharya, J., et al.: Dosimetric comparison of rapid arc, intensity modulated radiotherapy and 3D conformal radiotherapy plans in periampullary and pancreatic head carcinomas. J. Pancreas (JOP) 17(5), 466\u2013467 (2016)","journal-title":"J. Pancreas (JOP)"},{"issue":"3","key":"157_CR6","first-page":"665","volume":"115","author":"D Chang","year":"2009","unstructured":"Chang, D., Schellenberg, D., Shen, J., et al.: Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Am. Cancer Soc. 115(3), 665\u2013672 (2009)","journal-title":"Am. Cancer Soc."},{"issue":"1","key":"157_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"E Eisenhauer","year":"2009","unstructured":"Eisenhauer, E., Therasse, P., Bogaerts, J., et al.: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 45(1), 228\u2013247 (2009)","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"157_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"B Miler","year":"1981","unstructured":"Miler, B., Hoogstraten, B., Winkler, A.: WHO criteria in tumour response. Reporting results of cancer treatment. Cancer 47(1), 207\u2013214 (1981)","journal-title":"Cancer"},{"issue":"8","key":"157_CR9","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1516::AID-CNCR11>3.0.CO;2-0","volume":"79","author":"H Ishii","year":"1997","unstructured":"Ishii, H., Okada, S., Tokuuye, K., et al.: Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma. Cancer 79(8), 1516\u20131520 (1997)","journal-title":"Cancer"},{"issue":"4","key":"157_CR10","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0360-3016(99)00478-2","volume":"46","author":"T Andr\u00e9","year":"2000","unstructured":"Andr\u00e9, T., Balosso, J., Louvet, C., et al.: Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study. Int. J. Radiat. Oncol. Biol. Phys. 46(4), 903\u2013911 (2000)","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"157_CR11","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0360-3016(00)01527-3","volume":"49","author":"H Safran","year":"2001","unstructured":"Safran, H., Moore, T., Iannitti, D., et al.: Paclitaxel and concurrent radiation for locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 49(5), 1275\u20131279 (2001)","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"157_CR12","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0360-3016(01)01708-4","volume":"51","author":"G Boz","year":"2001","unstructured":"Boz, G., Paoli, A., Innocente, R., et al.: Radiotherapy and continuous infusion 5-fluorouracil in patients with nonresectable pancreatic carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 51(3), 736\u2013740 (2001)","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"157_CR13","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.ijrobp.2004.01.035","volume":"59","author":"A Morganti","year":"2004","unstructured":"Morganti, A., Valentini, V., Macchia, G., et al.: 5-fluorouracil\u2013based chemoradiation in unresectable pancreatic carcinoma: phase I-II dose-escalation study. Int. J. Radiat. Oncol. Biol. Phys. 59(5), 1454\u20131460 (2004)","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"157_CR14","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/sj.bjc.6602001","volume":"91","author":"T Okusaka","year":"2004","unstructured":"Okusaka, T., Ito, Y., Ueno, H., et al.: Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer. Br. J. Cancer 91(4), 673\u2013677 (2004)","journal-title":"Br. J. Cancer"},{"issue":"4","key":"157_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/PPO.0b013e31813c12b8","volume":"13","author":"M Saif","year":"2007","unstructured":"Saif, M., Black, G., Roy, S., et al.: Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase. Cancer J. 13(4), 247\u2013255 (2007)","journal-title":"Cancer J."},{"issue":"5","key":"157_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/sj.bjc.6604247","volume":"98","author":"P Hong","year":"2008","unstructured":"Hong, P., Park, Y., Jeon, J., et al.: Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. Br. J. Cancer 98(5), 881\u2013887 (2008)","journal-title":"Br. J. Cancer"},{"issue":"25","key":"157_CR17","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1200\/JCO.2009.21.8529","volume":"27","author":"C Crane","year":"2009","unstructured":"Crane, C., Winter, K., Regine, W., et al.: Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: radiation therapy oncology group RTOG 0411. J. Clin. Oncol. 27(25), 4096\u20134101 (2009)","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"157_CR18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/COC.0b013e3181c4c7a8","volume":"34","author":"K Shibuya","year":"2011","unstructured":"Shibuya, K., Oya, N., Fujii, T., et al.: Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer. Am. J. Clin. Oncol. 34(2), 115\u2013119 (2011)","journal-title":"Am. J. Clin. Oncol."},{"issue":"5","key":"157_CR19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/COC.0b013e3181e9c103","volume":"34","author":"R Cardenes","year":"2011","unstructured":"Cardenes, R., Moore, M., Johnson, S., et al.: A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier Oncology Group study. Am. J. Clin. Oncol. 34(5), 460\u2013465 (2011)","journal-title":"Am. J. Clin. Oncol."},{"issue":"1","key":"157_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijrobp.2010.01.027","volume":"80","author":"K Sudo","year":"2011","unstructured":"Sudo, K., Yamaguchi, T., Ishihara, T., et al.: Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 80(1), 119\u2013125 (2011)","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"157_CR21","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ijrobp.2003.11.003","volume":"59","author":"M Milano","year":"2004","unstructured":"Milano, M., Chmura, S., Garofalo, M., et al.: Intensity\u2013modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. Int. J. Radiat. Oncol. Biol. Phys. 59(2), 445\u2013453 (2004)","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"7","key":"157_CR22","first-page":"1","volume":"203","author":"S Son","year":"2012","unstructured":"Son, S., Song, J., Choi, B., et al.: The technical feasibility of an image-guided intensity-modulated radiotherapy (IG-IMRT) to perform a hypofractionated schedule in terms of toxicity and local control for patients with locally advanced or recurrent pancreatic cancer. Radiat. Oncol. 203(7), 1\u20138 (2012)","journal-title":"Radiat. Oncol."},{"issue":"9","key":"157_CR23","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/S0959-8049(02)00076-X","volume":"38","author":"M Lange de","year":"2002","unstructured":"de Lange, M., van Groeningen, J., Meijer, W., et al.: Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer. Eur. J. Cancer 38(9), 1212\u20131217 (2002)","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"157_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.022","volume":"76","author":"M Hoyer","year":"2005","unstructured":"Hoyer, M., Roed, H., Sengelov, L., et al.: Phase\u2013II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Green J. Radiotheraphy Oncol. 76(1), 48\u201353 (2005)","journal-title":"Green J. Radiotheraphy Oncol."},{"issue":"3","key":"157_CR25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ijrobp.2009.08.046","volume":"78","author":"A Mahadevan","year":"2010","unstructured":"Mahadevan, A., Jain, S., Goldstein, M., Miksad, R., et al.: Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 78(3), 735\u2013742 (2010)","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"8","key":"157_CR26","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1245\/s10434-010-1019-y","volume":"17","author":"F Polistina","year":"2010","unstructured":"Polistina, F., Costantin, G., Casamassima, F., et al.: Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration. Soc. Surg. Oncol. 17(8), 2092\u20132101 (2010)","journal-title":"Soc. Surg. Oncol."},{"issue":"10","key":"157_CR27","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s11605-010-1323-7","volume":"14","author":"M Didolkar","year":"2010","unstructured":"Didolkar, M., Coleman, C., Brenner, M., et al.: Image\u2013guided stereotactic radiosurgery for locally advanced pancreatic adenocarcinoma results of first 85 patients. J. Gastrointestinal Surg. 14(10), 1547\u20131559 (2010)","journal-title":"J. Gastrointestinal Surg."},{"issue":"2","key":"157_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jss.2011.07.044","volume":"174","author":"K Goyal","year":"2012","unstructured":"Goyal, K., Einstein, D., Ibarra, R., et al.: Stereotactic body radiation therapy for non-resectable tumors of the pancreas. J. Surg. Res. 174(2), 319\u2013325 (2012)","journal-title":"J. Surg. Res."},{"issue":"8","key":"157_CR29","first-page":"1","volume":"44","author":"M Gurka","year":"2013","unstructured":"Gurka, M., Colins, S., Slack, R., et al.: Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety. Radiat. Oncol. 44(8), 1\u20139 (2013)","journal-title":"Radiat. Oncol."},{"issue":"8","key":"157_CR30","first-page":"2246","volume":"7","author":"A Wolff","year":"2001","unstructured":"Wolff, A., Evans, B., Gravel, M., et al.: Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. Clin. Cancer Res. 7(8), 2246\u20132253 (2001)","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"157_CR31","first-page":"1523","volume":"25","author":"O Micke","year":"2005","unstructured":"Micke, O., Hesselmann, S., Bruns, F., et al.: Results and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy. Anticancer Res. 25(3), 1523\u20131530 (2005)","journal-title":"Anticancer Res."},{"issue":"2","key":"157_CR32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ijrobp.2011.07.013","volume":"83","author":"K Ogawa","year":"2012","unstructured":"Ogawa, K., Ito, Y., Hirokawa, N., et al.: Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on survival. Int. J. Radiat. Oncol. Biol. Phys. 83(2), 559\u2013565 (2012)","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"157_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijrobp.2012.03.059","volume":"85","author":"M Ikeda","year":"2013","unstructured":"Ikeda, M., Ioka, T., Ito, Y., Tonemoto, N., et al.: A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 85(1), 163\u2013169 (2013)","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"157_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijrobp.2012.02.051","volume":"84","author":"E Ben-Josef","year":"2012","unstructured":"Ben-Josef, E., Schipper, M., Francis, I., et al.: A phase I\/II trial of intensity-modulated radiation (IMRT) dose escalation with concurrent fixed- dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 84(5), 166\u20131171 (2012)","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"157_CR35","first-page":"1","volume":"7","author":"A Tunceroglu","year":"2012","unstructured":"Tunceroglu, A., Park, J., Balasubramanlan, S., et al.: Dose-painted intensity modulated radiation therapy improves local control for locally advanced pancreas cancer. Int. Sch. Res. Netw. 7(1), 1\u20136 (2012)","journal-title":"Int. Sch. Res. Netw."},{"issue":"1","key":"157_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijrobp.2012.11.020","volume":"86","author":"J Vainshtein","year":"2013","unstructured":"Vainshtein, J., Schipper, M., Zalupski, M., et al.: Prognostic significance of carbobydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiation therapy and concurrent full-dose gemcitabine: analysis of a prospective phase \u00bd dose escalation study. Int. J. Radiat. Oncol. Biol. Phys. 86(1), 96\u2013101 (2013)","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"157_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/MEG.0000000000000283","volume":"27","author":"J Lin","year":"2015","unstructured":"Lin, J., Jen, Y., Li, M., et al.: Comparing outcomes of stereotactic body radiotherapy with intensity-modulated radiotherapy for patients with locally advanced unresectable pancreatic cancer. Eur. J. Gastroenterol. Hepatol. 27(3), 259\u2013264 (2015)","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"1","key":"157_CR38","first-page":"11","volume":"24","author":"C Choi","year":"2006","unstructured":"Choi, C., Kim, M., Cho, C., et al.: Locally advanced, unresectable pancreatic cancer treated by stereotactic radiation therapy. Radiat. Oncol. J. 24(1), 11\u201320 (2006)","journal-title":"Radiat. Oncol. J."},{"issue":"5","key":"157_CR39","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.ijrobp.2009.01.042","volume":"75","author":"Y Seo","year":"2009","unstructured":"Seo, Y., Kim, M., Yoo, S., et al.: Stereotactic body radiation therapy boost in locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 75(5), 1456\u20131461 (2009)","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"157_CR40","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.2147\/OTT.S81939","volume":"8","author":"Y Song","year":"2015","unstructured":"Song, Y., Yuan, Z., Li, F., et al.: Analysis of clinical efficacy of CyberKnife\u00ae treatment for locally advanced pancreatic cancer. OncoTargets Ther. 8, 1427\u20131431 (2015)","journal-title":"OncoTargets Ther."},{"issue":"1","key":"157_CR41","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3892\/mmr.2015.4500","volume":"19","author":"J Chen","year":"2019","unstructured":"Chen, J., Chen, L., Yu, J., et al.: Meta-analysis of current chemotherapy regimens in advanced pancreatic cancer to prolong survival and reduce treatment-associated toxicities. Mol. Med. Rep. 19(1), 477\u2013489 (2019)","journal-title":"Mol. Med. Rep."},{"issue":"12","key":"157_CR42","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1080\/0284186X.2017.1342863","volume":"56","author":"J Park","year":"2017","unstructured":"Park, J., Hajj, C., Reyngold, M., et al.: Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer. Acta Oncol. 56(12), 1746\u20131753 (2017)","journal-title":"Acta Oncol."},{"issue":"22","key":"157_CR43","first-page":"1","volume":"1","author":"SP Ng","year":"2018","unstructured":"Ng, S.P., Koay, E.J.: Current and emerging radiotherapy strategies for pancreatic adenocarcinoma: stereotactic, intensity modulated and particle radiotherapy. Ann. Pancreat. Cancer. 1(22), 1\u201310 (2018)","journal-title":"Ann. Pancreat. Cancer."},{"issue":"2","key":"157_CR44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ijrobp.2016.10.030","volume":"97","author":"F Petrelli","year":"2017","unstructured":"Petrelli, F., Comito, T., Ghidini, A., et al.: Stereotactic body radiation therapy for locally advanced pancreatic cancer: a systematic review and pooled analysis of 19 trials. Int. J. Radiat. Oncol. Biol. Phys. 97(2), 313\u2013322 (2017)","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"157_CR45","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.dld.2014.01.001","volume":"46","author":"F Petrelli","year":"2014","unstructured":"Petrelli, F., Coinu, A., Borgonovo, K., Cabiddu, M., Ghilardi, M., Barni, S.: Polychemotherapy or gemcitabine in advanced pancreatic cancer: a meta-analysis. Dig. Liver Dis. 46(5), 452\u2013459 (2014)","journal-title":"Dig. Liver Dis."},{"issue":"3","key":"157_CR46","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S1499-3872(17)60022-5","volume":"16","author":"SF Jin","year":"2017","unstructured":"Jin, S.F., Fan, Z.K., Pan, L., Jin, L.M.: Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials. Hepatobiliary Pancreat. Dis. Int. 16(3), 236\u2013244 (2017)","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"1","key":"157_CR47","first-page":"13","volume":"4","author":"I Moraru","year":"2013","unstructured":"Moraru, I., Tai, A., Erickson, B., et al.: Radiation dose responses for chemoradiation therapy of pancreatic cancer: an analysis of compiled clinical data using biophysical models. Am. Soc. Radiat. Oncol. 4(1), 13\u201318 (2013)","journal-title":"Am. Soc. Radiat. Oncol."},{"key":"157_CR48","unstructured":"Gomes, A.: Impacto da Radioterapia no Tratamento do Adenocarcinoma Localmente Avan\u00e7ado do P\u00e2ncreas. Bachelor thesis. School of Health \u2013Polytechnic of Porto (2018)"},{"key":"157_CR49","doi-asserted-by":"crossref","unstructured":"Costa Ferreira, B., Dias, J., Gomes, A., et al.: Dose-response to different radiochemotherapy regimens in locally advanced pancreatic cancer. In: MEDICON2019 (2019)","DOI":"10.1007\/978-3-030-31635-8_156"},{"key":"157_CR50","unstructured":"Ferreira, B.C.: Biological optimization of angle of incidence and intensity modulation in breast and cervix cancer radiation therapy. Ph.D. Thesis. Stockholm University, Sweden (2004)"}],"container-title":["IFMBE Proceedings","XV Mediterranean Conference on Medical and Biological Engineering and Computing \u2013 MEDICON 2019"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-31635-8_157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T19:32:22Z","timestamp":1664479942000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-31635-8_157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,25]]},"ISBN":["9783030316341","9783030316358"],"references-count":50,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-31635-8_157","relation":{},"ISSN":["1680-0737","1433-9277"],"issn-type":[{"type":"print","value":"1680-0737"},{"type":"electronic","value":"1433-9277"}],"subject":[],"published":{"date-parts":[[2019,9,25]]},"assertion":[{"value":"25 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"MEDICON","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Mediterranean Conference on Medical and Biological Engineering and Computing","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Coimbra","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Portugal","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2019","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"26 September 2019","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"28 September 2019","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"medicon2019a","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"http:\/\/www.medicon2019.org","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}}]}}